The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...
VALNEVA Declaration of shares and voting rights January 31, 2025__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue ...
UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq: Saint Herblain, France Thursday, February 6, 2025, 12:00 Hrs [IST] Valneva SE, a specialty vacci ...
The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of ...
Nyrstar NV - Update in respect of dissolution or continuation of the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback